Compounds > lipoxin a4

lipoxin a4 and Alloxan Diabetes

lipoxin a4 has been researched along with Alloxan Diabetes in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (87.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
AlaEddine, M; Authier, H; Bernad, J; Bouschbacher, M; Coste, A; Dardenne, C; Lefèvre, L; Meunier, E; Pipy, B; Salon, M1
Bathina, S; Das, UN2
Ali-Shah, ST; Barry, M; Belton, O; Beuscart, O; Brennan, EP; Cooper, ME; Crean, D; Dai, A; de Gaetano, M; Derouiche, S; Dowdall, JF; Godson, C; Godson-Treacy, M; Gray, SP; Guiry, PJ; Jandeleit-Dahm, K; Kantharidis, P; Marai, M; McClelland, A; Mohan, M; Pickering, R; Sheehan, S; Tan, SM; Tikellis, C1
Bai, Y; He, Z; Jiang, H; Li, L; Wang, J; Yang, M1
Birnbaum, GD; Birnbaum, I; Birnbaum, Y; Nylander, S; Ye, Y1
Das, UN; Gundala, NKV; Naidu, VGM2

Other Studies

8 other study(ies) available for lipoxin a4 and Alloxan Diabetes

ArticleYear
Topical Aspirin Administration Improves Cutaneous Wound Healing in Diabetic Mice Through a Phenotypic Switch of Wound Macrophages Toward an Anti-inflammatory and Proresolutive Profile Characterized by LXA4 Release.
    Diabetes, 2022, 10-01, Volume: 71, Issue:10

    Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Aspirin; Diabetes Mellitus, Experimental; Inflammation; Leukotriene A4; Leukotriene B4; Lipoxins; Macrophages; Mice; Phenotype; Skin; Wound Healing

2022
PUFAs, BDNF and lipoxin A4 inhibit chemical-induced cytotoxicity of RIN5F cells in vitro and streptozotocin-induced type 2 diabetes mellitus in vivo.
    Lipids in health and disease, 2019, Dec-10, Volume: 18, Issue:1

    Topics: Alloxan; Animals; Arachidonic Acid; Benzo(a)pyrene; Brain-Derived Neurotrophic Factor; Cell Death; Cell Line, Tumor; Cytotoxins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Doxorubicin; Drug Interactions; Fatty Acids, Unsaturated; Insulin-Secreting Cells; Insulinoma; Lipoxins; Pancreatic Neoplasms; Rats; Rats, Wistar; Streptozocin

2019
Dysregulation of PI3K-Akt-mTOR pathway in brain of streptozotocin-induced type 2 diabetes mellitus in Wistar rats.
    Lipids in health and disease, 2018, Jul-24, Volume: 17, Issue:1

    Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gene Expression Regulation; Lipoxins; Male; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Wistar; Serine; Streptozocin; TOR Serine-Threonine Kinases

2018
Lipoxins Protect Against Inflammation in Diabetes-Associated Atherosclerosis.
    Diabetes, 2018, Volume: 67, Issue:12

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Atherosclerosis; Chemokine CCL2; Cytokines; Diabetes Mellitus, Experimental; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Lipoxins; Mice; Vascular Cell Adhesion Molecule-1

2018
Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines.
    Medical science monitor : international medical journal of experimental and clinical research, 2019, Apr-26, Volume: 25

    Topics: Animals; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Docosahexaenoic Acids; Fibrosis; Inflammation Mediators; Lipoxins; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Transforming Growth Factor beta

2019
Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine.
    Cardiovascular drugs and therapy, 2016, Volume: 30, Issue:6

    Topics: Adenosine; Animals; Apoptosis Regulatory Proteins; CARD Signaling Adaptor Proteins; Cardiotonic Agents; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Drug Synergism; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-1beta; Interleukin-6; Lipoxins; Male; Myocardial Reperfusion Injury; Myocardium; NLR Family, Pyrin Domain-Containing 3 Protein; Obesity; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Rats, Zucker; RNA, Messenger; Rosuvastatin Calcium; Ticagrelor

2016
Arachidonic acid and lipoxin A4 attenuate alloxan-induced cytotoxicity to RIN5F cells in vitro and type 1 diabetes mellitus in vivo.
    BioFactors (Oxford, England), 2017, Volume: 43, Issue:2

    Topics: Animals; Apoptosis; Arachidonic Acid; Cell Line, Tumor; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Gene Expression Regulation, Neoplastic; Humans; Insulinoma; Lipoxins; Neoplasm Proteins; Rats

2017
Arachidonic acid and lipoxinA4 attenuate streptozotocin-induced cytotoxicity to RIN5 F cells in vitro and type 1 and type 2 diabetes mellitus in vivo.
    Nutrition (Burbank, Los Angeles County, Calif.), 2017, Volume: 35

    Topics: Animals; Apoptosis; Arachidonic Acid; Blood Glucose; Cell Line; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Docosahexaenoic Acids; Eicosapentaenoic Acid; gamma-Linolenic Acid; Glucose Transporter Type 2; Homeodomain Proteins; Lipoxins; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide Synthase Type II; Pancreas; Rats; Rats, Wistar; Trans-Activators; Tumor Necrosis Factor-alpha

2017